Skip to the page

Data / Drug companies / Carbidopa and levodopa

Carbidopa and levodopa: 41 companies and 118 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Carbidopa and levodopa is listed in the FDA National Drug Code Directory by 41 companies, with 118 products in commercial distribution. 99 of the products (83.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release; capsule, extended release, and the newest product started marketing on July 13, 2026.

The request: Get every company that lists carbidopa and levodopa in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
41
Products
118
Generic (ANDA) products
99 (83.9%)
Application numbers
22
Routes
Oral, Enteral
Brand names
Carbidopa-levodopa, Rytary, Crexont, Sinemet, Duopa
openFDA record search
api.fda.gov

Companies that list carbidopa and levodopa

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Amneal Pharmaceuticals LLC8capsule, extended releaseNew drug applications (NDA)August 9, 2024
A-S Medication Solutions7tabletGeneric drugs (ANDA)November 28, 2022
Advagen Pharma Ltd5tablet; tablet, extended releaseGeneric drugs (ANDA)June 4, 2024
Coupler LLC5tabletGeneric drugs (ANDA)July 13, 2026
NCS HealthCare of Ky, LLC DBA Vangard Labs5tablet; tablet, extended releaseGeneric drugs (ANDA)May 1, 2024
Remedyrepack Inc.5capsule, extended release; tabletAuthorized generics (NDA)April 24, 2026
ScieGen Pharmaceuticals, Inc.5tablet; tablet, extended releaseGeneric drugs (ANDA)October 5, 2021
Sun Pharmaceutical Industries, Inc.5tablet; tablet, extended releaseGeneric drugs (ANDA)August 12, 2021
Zydus Pharmaceuticals USA Inc.4capsule, extended releaseAuthorized generics (NDA)October 20, 2025
Aurobindo Pharma Limited3tabletGeneric drugs (ANDA)November 28, 2022
AvKARE3tabletGeneric drugs (ANDA)February 21, 2024
Camber Pharmaceuticals, Inc.3tabletGeneric drugs (ANDA)May 27, 2025
Dr. Reddy's Laboratories Inc.3tabletGeneric drugs (ANDA)May 1, 2024
Proficient Rx LP3tabletGeneric drugs (ANDA)September 30, 2021
Rising Pharma Holdings, Inc.3tablet, orally disintegratingGeneric drugs (ANDA)January 8, 2025
Sun Pharmaceutical Industries, Inc.3tablet, orally disintegratingGeneric drugs (ANDA)December 15, 2014
Teva Pharmaceuticals USA, Inc.3tabletGeneric drugs (ANDA)December 15, 2023
TruPharma, LLC3tabletGeneric drugs (ANDA)September 21, 2022
Westminster Pharmaceuticals, LLC3tabletGeneric drugs (ANDA)September 30, 2021
XLCare Pharmaceuticals, Inc.3tabletGeneric drugs (ANDA)January 19, 2026
Accord Healthcare Inc.2tablet, extended releaseGeneric drugs (ANDA)June 13, 2013
Alembic Pharmaceuticals Inc.2tablet, extended releaseGeneric drugs (ANDA)June 6, 2019
Alembic Pharmaceuticals Limited2tablet, extended releaseGeneric drugs (ANDA)June 6, 2019
American Health Packaging2tabletGeneric drugs (ANDA)March 16, 2024
Amneal Pharmaceuticals NY LLC2tablet, extended releaseGeneric drugs (ANDA)December 21, 2022
Aphena Pharma Solutions - Tennessee, LLC2tabletGeneric drugs (ANDA)March 15, 2022
Bryant Ranch Prepack2tablet, extended releaseGeneric drugs (ANDA)October 5, 2021
Bryant Ranch Prepack2tabletGeneric drugs (ANDA)November 28, 2022
Cardinal Health 107, LLC2tabletGeneric drugs (ANDA)October 10, 2025
Major Pharmaceuticals2tabletGeneric drugs (ANDA)April 28, 2025
Mylan Institutional Inc.2tablet, extended releaseGeneric drugs (ANDA)February 1, 2002
Mylan Pharmaceuticals Inc.2tablet, extended releaseGeneric drugs (ANDA)April 26, 2000
Organon LLC2tabletNew drug applications (NDA)February 28, 2025
Radha Pharmaceuticals, Inc.2tablet, extended releaseGeneric drugs (ANDA)April 25, 2025
Safecor Health, LLC2tablet, extended releaseGeneric drugs (ANDA)March 13, 2026
AbbVie Inc.1suspensionNew drug applications (NDA)January 15, 2015
American Health Packaging1tabletGeneric drugs (ANDA)July 28, 2025
Aphena Pharma Solutions - Tennessee, LLC1tabletGeneric drugs (ANDA)January 19, 2026
AvPAK1tabletGeneric drugs (ANDA)June 23, 2026
Bryant Ranch Prepack1tabletGeneric drugs (ANDA)September 21, 2022
NuCare Pharmaceuticals,Inc.1tabletGeneric drugs (ANDA)October 28, 2008

Dosage forms

Dosage formProductsShare
Tablet6958.5%
Tablet, extended release2622%
Capsule, extended release1613.6%
Tablet, orally disintegrating65.1%
Suspension10.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)9983.9%
New drug applications (NDA)119.3%
Authorized generics (NDA)86.8%

Pharmacologic classes

ClassProducts
Aromatic Amino Acid118

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.